Show
Sort by
-
The value of measuring uncertainty in neural networks in dermoscopy
-
Comment on 'An evidence-based guide to SARS-CoV-2 vaccination of patients on immunotherapies in dermatology'
-
Assessing the minimal important change in the vitiligo extent score and the self-assessment vitiligo extent score
-
Standardizing serial photography for assessing and monitoring vitiligo : a core set of international recommendations for essential clinical and technical specifications
-
Navigating the landscape of core outcome set development in dermatology
-
Validation study of the Vitiligo Extent Score-plus
-
The Vitiligo Extent Score (VES) and the VESplus are responsive instruments to assess global and regional treatment response in patients with vitiligo
-
Development and validation of a patient-reported outcome measure in vitiligo : the Self Assessment Vitiligo Extent Score (SA-VES)
-
Melanoma-associated leukoderma and vitiligo cannot be differentiated based on blinded assessment by experts in the field
-
Rapidly progressive malignant melanoma in a patient treated with tocilizumab
-
Morphea-like skin reactions in patients treated with the cathepsin K inhibitor balicatib
-
Acquired pseudoxanthoma elasticum presenting after liver transplantation
-
Buschke-Ollendorff syndrome: A manifestation of a heterozygous nonsense mutation in the LEMD3 gene
-
- Conference Paper
- C3
- open access
High persistency of Glymatrix collagen in the correction of facial wrinkles after 15 months
-
Diagnostic ability of general practitioners and dermatologists in discriminating pigmented skin lesions.
-
Fibrillin immunofluorescence in pseudoxanthoma elasticum.
-
Abnormal fibrillin morphology in fibroblast cultures from patients with neonatal Marfan syndrome
-
Classification of pseudoxanthoma elasticum : report of a consensus conference
-
Pharmacokinetics and drug interactions of etretinate and acitretin
-
Level of education and the risk of malignant-melanoma
-
Verification of a formula for determination of preexcision surgical margins from fixed-tissue melanoma specimens
-
Influence of gender on survival in patients with stage-I malignant-melanoma